Page results
-
Welcome to the new London Sarcoma Service website, we hope that you can easily find the information that you need. We would be very grateful if you could speare a few minutes to give us some…
-
“I didn’t know what was wrong with me. All I could see was light, no people.” Prescilia was just nine when she suddenly lost all her vision. Tests revealed a rare type of benign…
-
Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.
-
A new research study at UCLH and UCL will investigate how a rare type of blood cancer develops and what types of treatment may be effective for patients.
-
The Edward Showler Foundation and UCL have forged a philanthropic partnership that will support pioneering research into clear cell sarcoma (CCS) – a rare type of soft tissue cancer with few…
-
We are excited to announce that we have some new additions to the team. Welcome to Melissa Millson and Emilia (Millie) Jewitt, who have joined the nursing team and to Charlotte Yarnton, who has…
-
Following the hottest summer on record in the capital, University College London Hospitals NHS Foundation Trust (UCLH) has launched ‘Critical Care For Our Climate’. The new strategy aims…
-
How COVID-19 impacts on the cardiovascular conditions
